The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is an emerging disease, where it can progress to non-alcoholic steatohepatitis (NASH) and lead to liver cirrhosis or liver cancer. Small intestinal bacterial overgrowth (SIBO) has been hypothesized to play an important role in NAFLD development a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fitriakusumah, Yoga, Lesmana, C. Rinaldi A., Bastian, Winda Permata, Jasirwan, Chyntia O. M., Hasan, Irsan, Simadibrata, Marcellus, Kurniawan, Juferdy, Sulaiman, Andri Sanityoso, Gani, Rino A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427876/
https://www.ncbi.nlm.nih.gov/pubmed/30894137
http://dx.doi.org/10.1186/s12876-019-0960-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427876/
https://www.ncbi.nlm.nih.gov/pubmed/30894137
http://dx.doi.org/10.1186/s12876-019-0960-x

Ejemplares similares